Prescription drug · ANDA
Ergomar Sublingual (Ergotamine tartrate) NDC 81279-104
Ergotamine tartrate 2 mg/1 · Tablet · Oral · Pangea Pharmaceuticals LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 81279-104-03 | 8127901040381279010403 | 1 BLISTER PACK in 1 CARTON (81279-104-03) / 3 TABLET in 1 BLISTER PACKMarketed from Feb 3, 2025 | |
| 81279-104-20 | 8127901042081279010420 | 2 BLISTER PACK in 1 CARTON (81279-104-20) / 10 TABLET in 1 BLISTER PACKMarketed from Feb 3, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Ergomar SublingualSuffix: Sublingual
- Generic name (nonproprietary)
- ergotamine tartrate
- Active ingredients
- Ergotamine tartrate — 2 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Pangea Pharmaceuticals LLCNDC labeler code 81279
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 087693
- Marketing start
- Listing expires
- Other FDA classes
- Ergotamines (Chemical structure)
- Identifiers
- Product ID 81279-104_2ef9fa55-cdc3-dc0a-e063-6394a90a0e5fSPL ID 2ef9fa55-cdc3-dc0a-e063-6394a90a0e5fSPL set ID a9582fdb-7ddd-4f69-aa7a-66247cdb8c92RxCUI 1293862, 1293864UNII MRU5XH3B48
- Pharmacologic class
- Ergotamine Derivative
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N481279010403followed by a unit qualifier and the quantityPackage 81279-0104-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Ergomar ® is indicated as therapy to abort or prevent vascular headache, e.g., migraine, migraine variants or so-called "histaminic cephalalgia".
Excerpt only. Read the full label for complete information.
About NDC 81279-104
- What is NDC 81279-104?
- 81279-104 is the product NDC for Ergomar Sublingual (ergotamine tartrate), Ergotamine tartrate 2 mg/1 tablet, listed with the FDA by Pangea Pharmaceuticals LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Ergomar Sublingual (Ergotamine Tartrate).
- What is the active ingredient?
- Ergotamine tartrate.
- Who is the labeler?
- Pangea Pharmaceuticals LLC, NDC labeler code 81279. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Ergomar Sublingual?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.